Introduction
Carbon nanomaterials such as carbon nanotubes (CNTs), [1] [2] carbon nanohorns (CNHs), 3 and graphene-related materials 4, 5 have attracted tremendous interest in the past decade due to their unique physicochemical properties. Carbon nanomaterials can find potential applications in various fields, including medical imaging and therapeutics. [5] [6] [7] [8] [9] [10] [11] Their large available surface area, nanoscale dimensions, and possibility of multiple surface functionalization strategies make them unique materials with a lot of promise for the design of drug delivery systems. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] In addition, they offer high conversion efficiency of near-infrared radiation energy into heat, which enables them to be agents for photothermal therapy. [22] [23] [24] Determination of the long-term fate of these carbon nanomaterials after administration into a living body is crucially important to allow the possibility for clinical translation.
To date, intensive efforts have been devoted toward assessment of safety issues related to carbon nanomaterials. In particular, several investigations aimed to evaluate the biodistribution of various functionalized CNTs and any potential adverse reaction. [25] [26] [27] [28] [29] [30] [31] Some of us previously reported that the surface functionalization of multiwalled CNTs determines the tissue distribution and excretion profile after intravenous administration. 29 The modifications with polyethylene glycol (PEG) or PEG-derived polymers Zhang et al have been reported to significantly extend blood circulation time of CNTs, reducing the risk of organ accumulation. [25] [26] Adequately functionalized multiwalled CNTs radiolabeled with [ 111 In] are retained in the reticuloendothelial system organs, such as the liver and spleen, but are also rapidly cleared from systemic blood circulation through the renal excretion route. 27, 28 The influence of type and degree of functionalization on the fate of injected CNTs has also been evaluated. 29 However, the effect of other structural parameters like the particle size (ie, short versus long) and shape (ie, small versus large diameter) has not been fully understood. The main reason is likely due to the difficulties of obtaining uniform different-sized CNTs in large quantities.
CNHs are considered good candidates for drug carriers due to the fact that they have a large surface area (1,464 m 2 /g) but also a wide inner-tube and inter-tube space in each individual horn (0.69 mL/g) after hole-opening. 32 Another advantage is that the CNHs are produced without catalysts 3 and therefore they are devoid of any toxic risks associated with residual metallic impurities. Recent studies have also shown that CNHs can be separated into different controlled sizes, 33, 34 and small-sized CNHs (S-CNHs) with uniform sizes ~20-50 nm can be easily obtained in large quantity by an oxidative disaggregation method. 34 S-CNHs are highly hydrophilic and remarkably resistant to cellular uptake by macrophages. 34 Histological observations following intravenous administration have shown that S-CNHs accumulate in the liver and spleen more slowly than large-sized CNHs (L-CNHs) of 80-120 nm in diameter. 35 This suggested that the biodistribution of CNHs may be size-dependent and it can eventually be further controlled by chemical functionalization.
To quantitatively and dynamically study the biodistribution of CNHs in vivo, we previously used Gd 2 O 3 as label. 36, 37 Unfortunately, this type of labeling is based on annealing processes at high temperature resulting in S-CNH reaggregation into larger nanoparticles. To further analyze the fate of CNHs of different sizes and to perform a more detailed quantitative investigation, we utilized radioactive indium in this study (In-111) to label CNHs and to follow their tissue distribution and whole-body excretion after intravenous administration. For this purpose, the labeling process was performed by an amidation reaction of oxidized CNHs with the chelating agent diethylenetriaminepentaacetic acid (DTPA), an approach that has been successfully used to investigate the pharmacokinetic profiles of CNTs. [27] [28] [29] By using this functionalization strategy, we can directly visualize the dynamic distribution of CNHs in whole body using single-photon emission computed tomography/computed tomography (SPECT/ CT) and quantitatively calculate the organ distribution using gamma scintigraphy. The data allowed comparison of the differences between S-CNHs and L-CNHs in organ accumulation as well as in their excretion profiles.
Experimental Materials
CNHs were synthesized by CO 2 laser ablation of graphite at room temperature in Ar gas without a metal catalyst. 3 S-and L-CNHs were prepared by oxidation as described in the following sections.
s-cNhs
Pristine CNHs (40 mg) were dispersed in 30 mL H 2 SO 4 (98%; Wako Pure Chemical Industries, Ltd., Osaka, Japan) and stirred for 4 hours at room temperature. 34 After cooling the suspension at 5°C, 10 mL HNO 3 solution (67%; Wako Pure Chemical Industries, Ltd.) was slowly added, followed by sonication for 4 hours in a bath-type sonicator (~100 W) at 20°C. After sonication, the suspension was filtered (membrane filter, pore size 0.2 µm), the S-CNHs on the filtration paper were washed with water and re-dispersed in water. The filtration and re-dispersion in water was repeated until the pH of the filtrate became neutral. The obtained S-CNHs were redispersed in water (100 mL), sonicated at approximately 20°C with a tip-type sonicator (~300 W) for 30 minutes, and centrifuged at 10,000 rpm for 30 minutes. S-CNHs were collected from the upper 80% of supernatant. The concentration of the S-CNHs in the suspension was estimated from the absorbance at 700 nm measured with a ultraviolet-visible-near-infrared radiation spectrometer (Lambda 19; PerkinElmer Inc., Waltham, MA, USA). From the volume of the supernatant (~80 mL) and the concentration of S-CNHs (~0.1 mg/mL), the yield of S-CNHs was estimated to be ~20%. The size of the S-CNHs was estimated by dynamic light scattering (FPAR-1000; Otsuka Electronic Co., Ltd., Osaka, Japan). To observe the morphologies of S-CNHs using transmission electron microscopy (TEM) (120 kV, 36 µA; 002B HRTEM; Topcon Corporation, Tokyo, Japan), one drop of S-CNH dispersion was placed on a Cu grid with ultrathin carbon film and dried at room temperature. Thermogravimetric analysis (TGA) of as-grown CNHs was performed in He using a TGA Q500 (TA Instruments, New Castle, USA) with a heating rate of 10°C⋅min
, while the other analyses were done using a TGA1 (Mettler Toledo, Schwerzenbach, Switzerland) apparatus from 30°C to 900°C with a ramp of 10°C⋅min -1 under N 2 using a flow rate of 50 mL⋅min -1 and platinum pans.
l-cNhs
The pristine CNHs were treated by light-assisted oxidation 38 to render them hydrophilic by generating oxygenated groups 
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radiolabeling whole-body images of carbon nanohorns in mice such as carboxylic groups. Briefly, pristine CNHs (40 mg) were dispersed in an aqueous solution of H 2 O 2 (30%, 60 mL) and heated at 70°C-80°C for 2 hours under irradiation using an Xe lamp. The resultant dispersion was filtered (membrane filter, pore size 0.2 µm), and the L-CNHs on the filter paper were washed and re-dispersed in water. The washing and redispersion were repeated four times. The obtained L-CNHs were re-dispersed in water (100 mL) by sonication in a water bath for 5 minutes. Their characteristics were similarly examined using the techniques described earlier. Cu grids with holey carbon were used for TEM observation of L-CNHs.
chemical functionalization and labeling with 111
In L-CNHs or S-CNHs were first treated with an amino-DTPA derivative 39 (see "Supplementary materials" for description of the synthesis of amino-DTPA, Figure S1 ) to allow chelation of 111 In (Figure 1 ). For this purpose, the CNHs (2.8 mg) were dispersed in oxalyl chloride (10 mL) using a water bath sonicator 20 W, 40 kHz (Transsonics Digitals Elma, Singen, Germany). The suspension was heated at reflux for 16 hours. After evaporation of excess oxalyl chloride under reduced pressure, the CNHs were dispersed in anhydrous tetrahydrofuran (THF) (1.9 mL) using water bath sonication. A solution of amino-DTPA (28 mg) and N,N-diisopropylethylamine (50 µL) in anhydrous dimethylformamide (DMF) (2.8 mL) was added. The suspension was sonicated in a water bath for 2 minutes and then heated at 65°C for 2 days. After cooling to room temperature, the solvents were evaporated under reduced pressure. Ammonium acetate buffer (0.2 M, pH 5.5, 30 mL) was added to the residue. The suspension was dispersed using water bath sonication and centrifuged at 4,500 rpm for 10 minutes. The supernatant was discarded and the precipitate was redispersed in ammonium acetate buffer. This sequence was repeated five times with ammonium acetate buffer and three times with deionized water. The precipitate was dispersed in deionized water using water bath sonication and the suspension was dialyzed in deionized water using 12-14 kDa molecular weight cut off (MWCO) dialysis membrane (Spectrum Laboratories, Inc., CA, USA) for 2 days.
For radiolabeling of the DTPA-S-CNHs or DTPA-LCNHs, equal volumes of 0.2 mg/mL solutions in water of each was mixed with 0.2 M ammonium acetate buffer (pH 5. (Figure 1, inset) .
In vivo experiments
All animal procedures were performed in compliance with the UK Home Office Code of Practice for the Housing and Care of Animals used in Scientific Procedures. They were conducted following approval by the Institutional Ethical Review Committee, according to the UKCCCR Guidelines (1998) and under Project License 70/7763 granted by the UK Home Office. Six to 8-week-old C57/BL/6 mice (15-20 g), were purchased from Harlan (Oxfordshire, UK). Mice were housed in groups of five with free access to water and kept at a temperature of 19°C-22°C and relative humidity of 45%-65%. Prior to performing the experiments, all animals were allowed to acclimatize for at least 7 days. The radiolabeled S-CNHs or L-CNHs (50 µg, 3-5 MBq) were injected via the tail vein of mice after anesthetization by isoflurane inhalation. Immediately after injection (t=0.5 hours) and at t=3.5 hours, t=24 hours, and t=48 hours, mice were imaged using the Nano-SPECT/CT scanner (Bioscan, Washington, D.C., USA). CT scans were performed at the beginning of each SPECT acquisition. SPECT images were obtained in 24 projections over 40-60 minutes using a four-head scanner with 1.4 mm pinhole collimators. All images were reconstructed with MEDISO software (Medical Imaging Systems, Budapest, Hungary). Fusion of SPECT and CT images was carried out using the PMOD software (PMOD Technologies, Zurich, Switzerland In]DTPA-L-CNHs labeled with approximately 0.5-2 MBq. Mice were then sacrificed at 1, 4, and 24 hours after injection, and blood and all major organs and tissues were collected, including: heart, lungs, liver, spleen, kidneys, muscle, skin, and bone. Urine and feces were pooled and collected after 24 hours. Each sample was weighed and counted on a gamma Counter (PerkinElmer Inc.), together with a dilution of the injected dose with dead time limit below 60%. The percentage injected dose per gram tissue was calculated, using four different mice for each time point.
Results and discussion characterization of s-cNhs and l-cNhs, and their
111
In labeling
The morphologies of S-CNHs and L-CNHs were shown in Figure 2A and 2B, respectively. S-CNHs contained individual nanohorns and small-sized aggregates (Figure 2A) , and their size was between 30 and 50 nm as estimated from dynamic light scattering ( Figure 2C ), in agreement with previous results. 34 L-CNHs maintain the original spherical form of aggregates ( Figure 2B ) with size range of ~80-120 nm ( Figure 2C ). TGA of as-grown CNHs, L-CNHs, and S-CNHs performed in an inert atmosphere is shown in Figure 2D . The weight loss observed for L-CNHs and S-CNHs is mainly caused by the emission of CO and CO 2 as a result of the thermal decomposition of oxygenated groups. 40 The concentration of carboxyl groups in the buffer solutions was estimated to be 6 µmol for S-CNHs and 2.5 µmol for L-CNHs per milligram of material, taking into account the quantities of carboxyl groups assessed from the weight loss at 400°C, which is due to the decomposition of carboxyl groups. 40 The COOH functions of both L-CNHs and S-CNHs were derivatized by amidation with the amino-DTPA derivative, via pre-activation of the carboxyl groups using oxalyl chloride. TGA performed in an inert atmosphere confirmed the successful functionalization of L-CNHs and S-CNHs with DTPA ( Figure 2D) . Indeed, the weight loss of DTPA-L-CNHs and DTPA-S-CNHs was higher compared to the L-CNHs and S-CNHs, respectively.
DTPA-amidated S-CNHs and L-CNHs were then labeled with 111 In, and the labeling efficiencies directly after the radiolabeling reaction corresponded to 64.6% and 95.2%, respectively ( Figure S2 Gamma scintigraphy was then used for the quantification of S-CNHs and L-CNHs in blood and the major organs and tissues like skin, liver, spleen, kidney, heart, lung, muscle, bone, stomach, and intestine at different time points (ie, 1, 4, and 24 hours) ( Figure 4 and Table 1 ). The control sample [
111 In]DTPA was used for comparison ( Figure S6 and In]DTPA-LCNHs reduced more rapidly in blood and only 0.82 µg/mL (0.4%) remained after 24 hours ( Figure 4A and B) . This suggests that the smaller CNHs were able to circulate longer, and their uptake by tissues was delayed. This behavior is common in the smaller nanoparticles which tend to reenter the blood In-labeled s-cNhs and l-cNhs. Images from left to right show whole-body, sagittal, frontal, and transverse views. The transverse cross-sectional images of spleen, liver, lung, kidney, and bladder are shown in the last columns. Abbreviations: DTPa, diethylenetriaminepentaacetic acid; sPecT/cT, single-photon emission computed tomography/computed tomography; cNhs, carbon nanohorns; s-cNhs, small-sized cNhs; l-cNhs, large-sized cNhs.
stream. 41 The larger [
In]DTPA-L-CNHs were taken up by the organs very rapidly at the first time points.
The S-CNH quantity in the liver (% ID/organ) was ~6.1% at 1 hour and increased significantly after 4 hours to 37.4%, remaining high at 24 hours (41.5%). The S-CNH quantity in the spleen was ~8.2% and increased a little with time ( Figure 4C ). The larger [
111 In]DTPA-L-CNHs were taken up by the organs very rapidly at the first time point. The L-CNH quantity in the liver was 73.7% (% ID/organ) at 1 hour, remaining unchanged at 4 and 24 hours ( Figure 4D ). The L-CNH quantity in the spleen was less than 5% at 1 hour, increasing a little with time. In other organs, quantities of S-and L-CNHs were very low, 2% (Figure 4) .
A more accurate analysis of the data is given by measuring the accumulation as percentage of the injected dose per gram of tissue (% ID/gram of tissue) ( Figure 4E and F) , to better express the affinity of CNH material for each tissue. The preferential accumulation of CNHs in the liver and spleen was again evident. However, the accumulation of 111 In]DTPA-L-CNHs expressed almost equal affinity to both organs. The size, sphericity, and deformability play a central role in accumulation of nanoparticles in tissues. Larger nanoparticles (150-200 nm) with spherical shapes tend to be trapped by the liver fenestra and recognized by Kupffer cells. 42 Smaller particles (of ~100 nm in diameter) with elongated shapes may be sequestered by the spleen, unless being deformable enough to cross the spleen reticular network. The control sample [ 111 In]DTPA showed rapid elimination from blood and only high kidney signals at early time points with no accumulation in other organs, with almost complete elimination after 24 hours ( Figure S7 , and Table 1 ).
cNh excretion
The values of % ID of S-CNHs or L-CNHs in the organs reported in Table 1 Abbreviations: h, hour(s); cNhs, carbon nanohorns; s-cNhs, small-sized cNhs; l-cNhs, large-sized cNhs; DTPa, diethylenetriaminepentaacetic acid.
amount of both S-CNHs and L-CNHs after 4 hours was 58.2% and 87.5%, respectively. Liberation of 111 In atoms from S-CNHs or L-CNHs was likely not happening because no decomplexation occurred in PBS and in serum at 37°C for 24 hours ( Figure S3 ). Thus, it is inferred that a certain amount of S-CNHs or L-CNHs was excreted mainly in urine within the first few hours, followed by the small/ trace amount excretions in urine and feces continuing for 48 hours (Figures 3 and S7) . The excreted quantity of S-CNHs was more than that of L-CNHs, detected by quantities in urine, with 8% of S-CNHs excreted compared to only approximately 5% of the L-CNHs ( Figure S7 ). This
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Zhang et al may have been the case because the smaller sized S-CNHs could avoid phagocytotic uptake more effectively than the larger L-CNHs, as has been observed in a previous in vitro study. 35 Also, small-sized nano-carbons were able to cross the glomerular filtration slits (40 nm) 28 more comfortably than L-CNHs.
Urinary excretion was further confirmed by semiquantification of the SPECT bladder signal. S-and L-CNH quantities detected in the bladder after 1 hour were ~3.50 and 2.16% of ID, respectively (Table S1 ). Both SPECT/CT and gamma scintigraphy data showed that overall small quantities of S-CNHs and L-CNHs (less than 10% ID) were detected in urine and feces at later time points of 24 and 48 hours (Table S1 and Figure S7 ). Although the preferential accumulation of S-CNHs and L-CNHs in the liver and spleen has been reported in our previous histological observations, 35 the results obtained in this study by SPECT quantitatively confirmed that the biodistribution of nano-carbons in vivo is size-dependent. In addition, the excretion profile of CNHs functionalized by [ 111 In]DTPA was different from Gd 2 O 3 -labeled CNHs (100 nm aggregates) coated with DSPE-PEG 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(PEG)] (5 kDa), 37 that were mainly excreted via the liver-bile ductduodenum route. 37 The similar results from single-wall carbon nanotubes (SWNTs) and graphene oxide also indicated that DTPA-functionalized SWNTs [27] [28] [29] or graphene oxide 43 exhibited faster clearance from the body than PEG-modified CNTs or graphene. 44 Therefore, we think that the surface functionalization of CNHs with non-bulky functional groups, like DTPA, can lead to a different biodistribution and excretion kinetic profile. This is effective in avoiding the uptake by phagocytes that may further facilitate excretion via both the urinary and liver-bile duct routes.
In addition, we did not find any signs of weakness, illness, or weight loss by visual inspection of the mouse and their organs after imaging.
Conclusion
We have studied the size-/shape-effect of CNHs on the biodistribution and excretion profile by using two types of CNHs (S-CNH: 30 nm and L-CNH: 100 nm). These CNHs were covalently functionalized with [ 111 In]DTPA and intravenously injected in mice. Their whole-body biodistribution profiles and excretion rates were studied by SPECT/CT and gamma scintigraphy. Both S-CNHs and L-CNHs accumulated mainly in the liver and spleen; however, S-CNHs exhibited higher affinity for the spleen. The larger, spherical L-CNHs accumulated in the liver and spleen to the same extent. A small amount of S-CNHs and L-CNHs was excreted within the first few hours after injection, followed by much slower excretion rates obtained after 48 hours. The excretion of S-CNHs was slightly faster than L-CNHs. Compared with the previous results for CNHs coated with phospholipid-PEG, the tissue distribution profile and kinetics of excretion determined for CNHs here were significantly different, most likely due to the differences in the material surface functionalization.
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Supplementary materials Materials and methods
All reagents and solvents were purchased from different commercial suppliers and used as received.
1 H and 13 C nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 300 MHz instrument (Bruker Corporation, Billerica, MA, USA). The peak values were obtained as ppm (δ) and referenced to the solvent. The resonance multiplicity is indicated as s (singlet), t (triplet), m (multiplet), and br (broad). Liquid chromatography-mass spectrometry analyses were performed on a Thermo Fisher Finnigan LCQ Advantage Max system (Thermo Fisher Scientific, Waltham, MA, USA). Thermogravimetric analysis was performed using a Thermogravimetric analysis 1 (Mettler Toledo, Schwerzenbach, Switzerland) apparatus from 100°C to 900°C with a ramp of 10°C min -1 under N 2 (flow rate of 50 mL⋅min -1 ) and platinum pans.
The amino-diethylenetriaminepentaacetic acid derivative was synthesized from the t-Bu-protected diethylenetriaminepentaacetic acid ligand reported in Marangon et al. 1 The latter (665 mg) was stirred in trifluoroacetic acid (TFA) (8 mL) and deionized water (0.89 mL) for 17 hours. Abbreviations: h, hour(s); DTPa, diethylenetriaminepentaacetic acid; cNhs, carbon nanohorns; s-cNhs, small-sized cNhs; l-cNhs, large-sized cNhs.
